Patent ID: 9566291
Date: 2017-02-14
CPC Classifications: A23L,A23V,A23Y,A61K,A61P

Claim:
1. A method for reducing the occurrence of respiratory tract infections in a human infant between 0 and 2 years of age suffering from respiratory tract infections, said method comprising orally administering to the infant an infant formula composition free of human milk comprising: (a) 0.1 to 12 grams indigestible galacto-oligosaccharides per 100 gram dry weight of the composition; and (b) at least 5 weight % based on total dry weight of the composition of a digestible galactose saccharide, said saccharide being selected from the group consisting of galactose and digestible galactose having at least two terminal saccharide units, wherein one terminal saccharide unit is glucose or galactose, and the other terminal saccharide is galactose or fucose, wherein the infant formula composition does not comprise a probiotic.